EGFR-mutant lung cancer | sciencenewsnet.in

Breaking News

Roy Choi Will Speak to Cal State Fullerton’s Class of 2024

Compact quantum light processing

Researchers develop a new way to safely boost immune cells to fight cancer

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

RCT finds calories may be more important than meal timing when it comes to weight loss

Newer antibiotics underprescribed for highly resistant infections

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

20 Apr, 2024

MD Anderson Research Highlights: ESMO 2023 Special Edition

October 15, 2023 sarah JonasResearch Results

This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types.

MD Anderson EGFR Classification licensed by BostonGene and Tempus to provide new insight on atypical mutations in lung cancer

January 19, 2023 sarah JonasAnnouncement

MD Anderson announced licensing agreements with BostonGene and Tempus for the MD Anderson EGFR Classification, which organizes EGFR mutations into subgroups that may guide clinical decision-making.